1. Home
  2. LTRN vs SCWO Comparison

LTRN vs SCWO Comparison

Compare LTRN & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • SCWO
  • Stock Information
  • Founded
  • LTRN 2013
  • SCWO 2021
  • Country
  • LTRN United States
  • SCWO United States
  • Employees
  • LTRN N/A
  • SCWO N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • SCWO Environmental Services
  • Sector
  • LTRN Health Care
  • SCWO Utilities
  • Exchange
  • LTRN Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • LTRN 36.1M
  • SCWO 39.9M
  • IPO Year
  • LTRN 2020
  • SCWO N/A
  • Fundamental
  • Price
  • LTRN $3.05
  • SCWO $0.43
  • Analyst Decision
  • LTRN Strong Buy
  • SCWO
  • Analyst Count
  • LTRN 1
  • SCWO 0
  • Target Price
  • LTRN $25.00
  • SCWO N/A
  • AVG Volume (30 Days)
  • LTRN 71.9K
  • SCWO 3.2M
  • Earning Date
  • LTRN 05-15-2025
  • SCWO 05-15-2025
  • Dividend Yield
  • LTRN N/A
  • SCWO N/A
  • EPS Growth
  • LTRN N/A
  • SCWO N/A
  • EPS
  • LTRN N/A
  • SCWO N/A
  • Revenue
  • LTRN N/A
  • SCWO $673,267.00
  • Revenue This Year
  • LTRN N/A
  • SCWO $5,945.19
  • Revenue Next Year
  • LTRN N/A
  • SCWO $106.82
  • P/E Ratio
  • LTRN N/A
  • SCWO N/A
  • Revenue Growth
  • LTRN N/A
  • SCWO 161.19
  • 52 Week Low
  • LTRN $2.55
  • SCWO $0.25
  • 52 Week High
  • LTRN $6.40
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 40.80
  • SCWO 64.72
  • Support Level
  • LTRN $2.85
  • SCWO $0.26
  • Resistance Level
  • LTRN $3.23
  • SCWO $0.68
  • Average True Range (ATR)
  • LTRN 0.38
  • SCWO 0.07
  • MACD
  • LTRN -0.09
  • SCWO 0.02
  • Stochastic Oscillator
  • LTRN 12.41
  • SCWO 41.52

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: